Pfizer gets nod to enter into Marketing and Supply Agreement with Mylan Pharmaceuticals

21 Feb 2025 Evaluate

Pfizer has received approval for a proposal to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals (Mylan) for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane. The said Marketing and supply agreement will be for a period of 5 years within the territory of India.

Mylan has a good presence in Central Nervous System therapy area with skilled resources for engagement with super specialists namely Neurologist and Psychiatrist. This arrangement with Mylan will enhance distribution and in clinic presence of the products of the company. The Board of Directors of the company at their Meeting held on February 20, 2025 has approved the same. 

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.


Pfizer Share Price

4003.95 31.65 (0.80%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...